Evidence map›Paper›PMID 27199363›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2016

Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.

Nimali P Withana, Toshinobu Saito, Xiaowei Ma, Megan Garland, Changhao Liu, Hisanori Kosuge, Myriam Amsallem, Martijn Verdoes, Leslie O Ofori, Michael Fischbein and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 61 citations in OpenAlex.

  1. Next-generation molecular imaging of cardiac fibrosis.The international journal of cardiovascular imaging · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. [Theranostics · 2020
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Nimali P WithanaDepartment of Pathology, Stanford University School of Medicine, Stanford, California.
Toshinobu SaitoDepartment of Medicine (Cardiovascular), Stanford University School of Medicine, Stanford, California.
Xiaowei MaDepartment of Radiology, Stanford University School of Medicine, Stanford, California.
Megan GarlandDepartment of Pathology, Stanford University School of Medicine, Stanford, California.
Changhao LiuDepartment of Radiology, Stanford University School of Medicine, Stanford, California.
Hisanori KosugeDepartment of Medicine (Cardiovascular), Stanford University School of Medicine, Stanford, California.
Myriam AmsallemDepartment of Medicine (Cardiovascular), Stanford University School of Medicine, Stanford, California.
Martijn VerdoesDepartment of Pathology, Stanford University School of Medicine, Stanford, California.
Leslie O OforiDepartment of Pathology, Stanford University School of Medicine, Stanford, California.
Michael FischbeinDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California; and.
Mamoru ArakawaDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California; and.
Zhen ChengDepartment of Radiology, Stanford University School of Medicine, Stanford, California mbogyo@stanford.edu zcheng@stanford.edu.
Michael V McConnellDepartment of Medicine (Cardiovascular), Stanford University School of Medicine, Stanford, California.
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, California Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California mbogyo@stanford.edu zcheng@stanford.edu.
Stanford University · USStanford Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are cellular mediators of vascular inflammation and are involved in the formation of atherosclerotic plaques. These immune cells secrete proteases such as matrix metalloproteinases and cathepsins that contribute to disease formation and progression. Here, we demonstrate that activity-based probes (ABPs) targeting cysteine cathepsins can be used in murine models of atherosclerosis to noninvasively image activated macrophage populations using both optical and PET/CT methods. The probes can also be used to topically label human carotid plaques demonstrating similar specific labeling of activated macrophage populations.

methodsMacrophage-rich carotid lesions were induced in FVB mice fed on a high-fat diet by streptozotocin injection followed by ligation of the left common carotid artery. Mice with carotid atherosclerotic plaques were injected with the optical or dual-modality probes BMV109 and BMV101, respectively, via the tail vein and noninvasively imaged by optical and small-animal PET/CT at different time points. After noninvasive imaging, the murine carotid arteries were imaged in situ and ex vivo, followed by immunofluorescence staining to confirm target labeling. Additionally, human carotid plaques were topically labeled with the probe and analyzed by both sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunofluorescence staining to confirm the primary targets of the probe.

resultsQuantitative analysis of the signal intensity from both optical and PET/CT imaging showed significantly higher levels of accumulation of BMV109 and BMV101 (P < 0.005 and P < 0.05, respectively) in the ligated left carotid arteries than the right carotid or healthy arteries. Immunofluorescence staining for macrophages in cross-sectional slices of the murine artery demonstrated substantial infiltration of macrophages in the neointima and adventitia of the ligated left carotid arteries compared with the right. Analysis of the human plaque tissues by sodium dodecyl sulfate polyacrylamide gel electrophoresis confirmed that the primary targets of the probe were cathepsins X, B, S, and L. Immunofluorescence labeling of the human tissue with the probe demonstrated colocalization of the probe with CD68, elastin, and cathepsin S, similar to that observed in the experimental carotid inflammation murine model.

conclusionWe demonstrate that ABPs targeting the cysteine cathepsins can be used in murine models of atherosclerosis to noninvasively image activated macrophage populations using both optical and PET/CT methods. The probes could also be used to topically label human carotid plaques demonstrating similar specific labeling of activated macrophage populations. Therefore, ABPs targeting the cysteine cathepsins are potentially valuable new reagents for rapid and noninvasive imaging of atherosclerotic disease progression and plaque vulnerability.

Indexed as

AnimalsAtherosclerosisCarotid ArteriesCathepsinsHumansMacrophagesMiceMolecular ImagingMolecular ProbesPositron-Emission TomographyCathepsinsMolecular Probesactivity-based probesanimal imagingatherosclerosiscathepsinsinflammationmacrophagesopticalPETPET/CTvascular

Identifiers

PMID27199363
PMCPMC5367444
OpenAlexW2395832195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.